A protocol deviation refers to any departure from the approved study protocol in a clinical trial. This can include changes in procedures, dosing, timing, or any other aspect of the study that differs from what was originally outlined and approved.
Protocol deviations can be minor or major, and may be intentional or unintentional. They are typically documented and reported to ensure transparency and to assess any potential impact on the study’s integrity or participant safety.
Protocol deviations are crucial in clinical research as they can affect the validity and reliability of study results. Understanding and documenting these deviations allows researchers to assess their impact on data integrity and participant safety, ensuring the overall quality of the clinical trial.
Recognizing protocol deviations is essential for regulatory compliance and ethical conduct in clinical studies. It enables sponsors and investigators to implement corrective actions, improve study protocols, and maintain transparency with regulatory authorities, ultimately contributing to the advancement of medical knowledge and patient care.
Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…
The Axcellant team recently attended the International Conference on Nuclear Cardiology (ICNC) in Berlin – one of the most important…
Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…
Copyright @ 2026 Axcellant